Table II.
Absolute T-cell and NK cell number at diagnosis
| Prognostic factors/variable | Number of patients |
Median NK cell count (× 109/L) |
Median T cell count (× 109/L) |
||
|---|---|---|---|---|---|
| All patients | 166 | 0.54 | 2.06 | ||
|
| |||||
| Rai Stage at diagnosis | p=0.13 | p=0.81 | |||
| 0 | 113 | 0.59 | 2.06 | ||
| I/II | 40 | 0.45 | 1.97 | ||
| III/IV | 8 | 0.25 | 2.39 | ||
|
| |||||
| CD38 | p=0.16 | p=0.77 | |||
| Positive (≥30%) | 54 | 0.48 | 2.11 | ||
| Negative (<30%) | 107 | 0.59 | 2.02 | ||
|
| |||||
| ZAP-70 | p=0.71 | p=0.73 | |||
| Positive (≥20%) | 12 | 0.48 | 2.30 | ||
| Negative (<20%) | 34 | 0.59 | 2.19 | ||
|
| |||||
| IgVH gene mutation status | p=0.17 | p=0.23 | |||
| Unmutated | |||||
| Mutated | 27 | 0.45 | 1.64 | ||
| 41 | 0.63 | 2.25 | |||
|
| |||||
| FISH result | p=0.30 | p=0.24 | |||
| 13q- | 26 | 0.53 | 2.17 | ||
| Normal | 18 | 0.56 | 1.62 | ||
| +12 | 15 | 0.54 | 2.73 | ||
| 11q-/17p- | 11 | 0.29 | 1.24 | ||